Activity Provided By:

University of Chicago Pritzker School of Medicine

All in for ALL: Mitigating VOD Risk in Patients Being Treated for R/R ALL

Overview / Abstract:	Are you involved with mitigating veno-occlusive disease (VOD) risk in patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL)? Are you current with the latest guidance regarding R/R ALL treatment? The therapeutic landscape for R/R ALL now comprises of a wide variety of agents. Stay abreast of the most recent R/R ALL treatment updates as well as the latest in how to manage VOD risk in patients with R/R ALL. Host a complimentary Virtual Visiting Professorship Program designed to deliver relevant and personalized education to your clinicians as leading experts how to manage VOD risk in patients with R/R ALL.
Expiration	Mar 31, 2023
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE
Format	Grand Rounds
Credits / Hours	1.0
Accreditation	ACCME
Presenters / Authors / Faculty	Chair: Partow Kebriaei, MD Professor, Department of Stem Cell Transplantation Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston, TX Co-Chair: Richard Larson, MD Professor of Medicine Section of Hematology/Oncology The University of Chicago Chicago, IL Faculty: Nelson Chao, MD, MBA Professor of Immunology Chief, Division of Hematological Malignancies Chief, Division of Cell Therapy Director, Global Oncology, Duke Global Health Institute Duke University Medical Center Durham, NC Hongtao Liu, MD, Ph.D Associate Professor of Medicine Co-director, Apheresis Unit Medical Director, Clinical Cellular Therapy Laboratory Department of Medicine Section of Hematology/Oncology The University of Chicago Medical Center Chicago, IL Marlise Luskin, MD, MSCE Assistant Professor of Medicine Harvard Medical School Oncologist - Adult Leukemia Group Dana-Farber Cancer Institute Boston, MA Kris Mahadeo, MD, MPH Associate Professor Department of Pediatrics Patient Care Division of Pediatrics, Department of Stem Cell Transplantation The University of Texas MD Anderson Cancer Center Houston, TX
Activity Specialities / Related Topics	Oncology / Cancer / Radiation Therapy
Sponsors / Supporters / Grant Providers	Supported by an educational grant from Pfizer Inc. Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Keywords / Search Terms	ACHL acute lymphoblastic leukemia, relapsed/refractory, veno-occlusive disease, VOD, hematopoietic stem cell transplant, HSCT, R/R ALL, immunotherapies, blinatumomab, inotuzumab ozogamicin, tisangenlecleucel, hematology, oncology, bone marrow transplant, Ph+, Ph- B-ALL, T-ALL, sinusoidal obstruction syndrome, defibrotide Free CE CME Seminar CE CME
LIVE Activity Location Details	Date(s) 11-30--0001 Various- Based on your site needs

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map